Your browser doesn't support javascript.
loading
Impact of donor ventricular function on heart transplantation outcomes.
Firoz, Ahad; Yanagida, Roh; Hamad, Eman; Kashem, Mohammed; Toyoda, Yoshiya.
Afiliação
  • Firoz A; Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA.
  • Yanagida R; Department of Cardiovascular Surgery, Temple University Hospital, Philadelphia, Pennsylvania, USA.
  • Hamad E; Heart and Vascular Institute, Temple University Hospital, Philadelphia, Pennsylvania, USA.
  • Kashem M; Department of Cardiovascular Surgery, Temple University Hospital, Philadelphia, Pennsylvania, USA.
  • Toyoda Y; Department of Cardiovascular Surgery, Temple University Hospital, Philadelphia, Pennsylvania, USA.
Clin Transplant ; 37(8): e14988, 2023 08.
Article em En | MEDLINE | ID: mdl-37039483
ABSTRACT

BACKGROUND:

Some heart transplant (HTx) centers have expanded their donor eligibility criteria in response to the organ shortage; one area of active interest involves utilizing hearts with ventricular dysfunction. Our study seeks to identify if a relationship exists between donor left ventricular ejection fraction (LVEF) and ischemic time or donor age on HTx outcomes.

METHODS:

We performed a retrospective analysis on adult patients who had a HTx between 1996 and 2021 (n = 46,936). Donor LVEF (dLVEF) values were categorized into three groups <50%, 50%-70%, and >70%. Ischemic time and donor age were stratified into four groups ≤2.0, 2.1-3.0, 3.1-4.0, >4.0 h, and ≤30, 31-40, 41-50, >50 years, respectively. The outcome of interest was long-term survival.

RESULTS:

Multivariable survival analysis found a slight increase in overall mortality risk for patients with donor ejection fractions <50% (HR = 1.16, p = .013). However, subsequent subgroup investigation discovered that this elevated hazard was only applicable when ischemic time was prolonged to >3.0 h (3.1-4.0 h HR = 1.23, p = .024; > 4.0 h HR = 1.52, p < .001). There was no significant difference in survival between dLVEF groups when ischemic time was limited to ≤3.0 h or when stratified by donor age.

CONCLUSION:

HTx patients with a low donor ejection fraction have comparable survival to recipients with a normal dLVEF when ischemic time is limited to ≤3.0 h. Reduced dLVEF does not appear to be sensitive to advanced donor age. The clinical implications of our study may encourage the recruitment of more donor hearts for transplantation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Coração Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans / Middle aged Idioma: En Revista: Clin Transplant Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Coração Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans / Middle aged Idioma: En Revista: Clin Transplant Ano de publicação: 2023 Tipo de documento: Article